As of 2026-06-18, the EV/EBITDA ratio of Biosynex SA (ALBIO.PA) is -13.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBIO.PA's latest enterprise value is 74.59 mil EUR. ALBIO.PA's TTM EBITDA according to its financial statements is -5.49 mil EUR. Dividing these 2 quantities gives us the above ALBIO.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 7.7x | 6.4x |
| Forward P/E multiples | 5.2x - 8.3x | 6.8x |
| Fair Price | (4.55) - (5.30) | (4.96) |
| Upside | -586.5% - -666.0% | -630.0% |
| Date | EV/EBITDA |
| 2026-06-15 | -13.57 |
| 2026-06-12 | -13.49 |
| 2026-06-11 | -13.53 |
| 2026-06-10 | -13.68 |
| 2026-06-09 | -13.60 |
| 2026-06-08 | -13.62 |
| 2026-06-05 | -13.56 |
| 2026-06-04 | -13.49 |
| 2026-06-03 | -13.53 |
| 2026-06-02 | -13.70 |
| 2026-06-01 | -13.87 |
| 2026-05-29 | -13.97 |
| 2026-05-28 | -14.01 |
| 2026-05-27 | -14.01 |
| 2026-05-26 | -14.26 |
| 2026-05-25 | -14.38 |
| 2026-05-22 | -13.92 |
| 2026-05-21 | -14.02 |
| 2026-05-20 | -14.04 |
| 2026-05-19 | -14.26 |
| 2026-05-18 | -13.56 |
| 2026-05-15 | -13.72 |
| 2026-05-14 | -13.53 |
| 2026-05-13 | -14.11 |
| 2026-05-12 | -14.82 |
| 2026-05-11 | -15.75 |
| 2026-05-08 | -14.14 |
| 2026-05-07 | -13.49 |
| 2026-05-06 | -12.90 |
| 2026-05-05 | -13.05 |
| 2026-05-04 | -13.12 |
| 2026-04-30 | -13.15 |
| 2026-04-29 | -13.12 |
| 2026-04-28 | -13.06 |
| 2026-04-27 | -13.09 |
| 2026-04-24 | -13.23 |
| 2026-04-23 | -13.23 |
| 2026-04-22 | -13.23 |
| 2026-04-21 | -13.35 |
| 2026-04-20 | -13.29 |
| 2026-04-17 | -13.32 |
| 2026-04-16 | -13.27 |
| 2026-04-15 | -13.29 |
| 2026-04-14 | -13.29 |
| 2026-04-13 | -13.27 |
| 2026-04-10 | -13.27 |
| 2026-04-09 | -13.27 |
| 2026-04-08 | -13.36 |
| 2026-04-07 | -13.29 |
| 2026-04-02 | -13.02 |